BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 8928194)

  • 1. Anosmia following head trauma: preliminary study of steroid treatment.
    Ikeda K; Sakurada T; Takasaka T; Okitsu T; Yoshida S
    Tohoku J Exp Med; 1995 Dec; 177(4):343-51. PubMed ID: 8928194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Medical treatment of traumatic anosmia.
    Jiang RS; Twu CW; Liang KL
    Otolaryngol Head Neck Surg; 2015 May; 152(5):954-8. PubMed ID: 25715353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olfactory dysfunction in head injured workers.
    Ogawa T; Rutka J
    Acta Otolaryngol Suppl; 1999; 540():50-7. PubMed ID: 10445080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of systemic corticosteroid treatment for anosmia with nasal and paranasal sinus disease.
    Ikeda K; Sakurada T; Suzaki Y; Takasaka T
    Rhinology; 1995 Sep; 33(3):162-5. PubMed ID: 8560170
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In response to Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.
    Hosseinpoor M; Kabiri M; Bakhshaee M
    Laryngoscope; 2023 Apr; 133(4):E31. PubMed ID: 36495295
    [No Abstract]   [Full Text] [Related]  

  • 6. Olfactory dysfunction in patients with head trauma.
    Doty RL; Yousem DM; Pham LT; Kreshak AA; Geckle R; Lee WW
    Arch Neurol; 1997 Sep; 54(9):1131-40. PubMed ID: 9311357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The diagnosis of a conductive olfactory loss.
    Seiden AM; Duncan HJ
    Laryngoscope; 2001 Jan; 111(1):9-14. PubMed ID: 11192906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In reference to Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.
    Vaira LA; De Riu G; Boscolo-Rizzo P; Hopkins C; Lechien JR
    Laryngoscope; 2023 Apr; 133(4):E29-E30. PubMed ID: 36495301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparative study of brain perfusion single-photon emission computed tomography and magnetic resonance imaging in patients with post-traumatic anosmia.
    Atighechi S; Salari H; Baradarantar MH; Jafari R; Karimi G; Mirjali M
    Am J Rhinol Allergy; 2009; 23(4):409-12. PubMed ID: 19671257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Topical corticosteroids applied with a squirt system are more effective than a nasal spray for steroid-dependent olfactory impairment.
    Shu CH; Lee PL; Shiao AS; Chen KT; Lan MY
    Laryngoscope; 2012 Apr; 122(4):747-50. PubMed ID: 22302665
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Local and systemic administration of corticosteroids in the treatment of olfactory loss.
    Heilmann S; Huettenbrink KB; Hummel T
    Am J Rhinol; 2004; 18(1):29-33. PubMed ID: 15035568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Investigation of prognostic factors for post-traumatic olfactory dysfunction.
    Fan LY; Kuo CL; Lirng JF; Shu CH
    J Chin Med Assoc; 2015 May; 78(5):299-303. PubMed ID: 25801491
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The influence of head injury on olfactory and gustatory function.
    Schofield PW; Doty RL
    Handb Clin Neurol; 2019; 164():409-429. PubMed ID: 31604560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anosmia and hyposmia.
    Gaines AD
    Allergy Asthma Proc; 2010; 31(3):185-9. PubMed ID: 20615320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of decline and chance of improvement in olfaction among patients with post-traumatic olfactory loss.
    Kuo CL; Shu CH
    J Laryngol Otol; 2015 Dec; 129(12):1201-7. PubMed ID: 26490496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Olfactory bulb volume in Taiwanese patients with posttraumatic anosmia.
    Jiang RS; Chai JW; Chen WH; Fuh WB; Chiang CM; Chen CC
    Am J Rhinol Allergy; 2009; 23(6):582-4. PubMed ID: 19958606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Posttraumatic anosmia.
    Zusho H
    Arch Otolaryngol; 1982 Feb; 108(2):90-2. PubMed ID: 7059319
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical corticosteroid treatment of anosmia associated with nasal and sinus disease.
    Mott AE; Cain WS; Lafreniere D; Leonard G; Gent JF; Frank ME
    Arch Otolaryngol Head Neck Surg; 1997 Apr; 123(4):367-72. PubMed ID: 9109781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intranasal Corticosteroid Treatment on Recovery of Long-Term Olfactory Dysfunction Due to COVID-19.
    Hosseinpoor M; Kabiri M; Rajati Haghi M; Ghadam Soltani T; Rezaei A; Faghfouri A; Poustchian Gholkhatmi Z; Bakhshaee M
    Laryngoscope; 2022 Nov; 132(11):2209-2216. PubMed ID: 36054369
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Brain lesion-pattern analysis in patients with olfactory dysfunctions following head trauma.
    Lötsch J; Ultsch A; Eckhardt M; Huart C; Rombaux P; Hummel T
    Neuroimage Clin; 2016; 11():99-105. PubMed ID: 26937377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.